Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011–2020

Gandhi, Gian; Lydon, Patrick; Cornejo, Santiago; Brenzel, Logan; Wrobel, Sandra J.; Chang, Hung Chih

doi:10.1016/j.vaccine.2013.01.036

Cited by 43 publications

(40 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Such a profile is consistent with the expected performance targets and peaks in demand for pneumococcal, rotavirus and HPV vaccines, 8 as well as with estimates from the global investment framework for women and children's health. 9 A detailed review of the composition of costs reveals that investments in the components that are needed for service delivery represent 63% of total investments (Fig.…”

Section: Perspectivessupporting

confidence: 80%

“…8 The estimated non-vaccine costs to the health system of delivering routine vaccination will require an investment of 25.4 billion United States dollars (US$) during this decade (Fig. 1).…”

Section: Perspectivesmentioning

confidence: 99%

“…According to projections of future financial flows for vaccination in 2011 to 2020, 65% of the need for routine vaccination will not be met. 8 Strategies to fill the expected funding gaps are all the more pressing because of the impact that front-loading investments in earlier years would exert on countries' readiness to introduce new vaccines and because achieving certain infrastructural improvements can take several years. The EPI's continued success and the health and economic benefits that immunization will confer during the decade from 2011 to 2020 will hinge on sufficient financing of the non-vaccine components of routine vaccination services.…”

Section: Perspectivesmentioning

confidence: 99%

See 2 more Smart Citations

Health system cost of delivering routine vaccination in low- and lower-middle income countries: what is needed over the next decade?

Lydon

Gandhi

Vandelaer

et al. 2014

Bull. World Health Organ.

Self Cite

View full text Add to dashboard Cite

Section: Perspectivessupporting

confidence: 80%

Section: Perspectivesmentioning

confidence: 99%

Section: Perspectivesmentioning

confidence: 99%

See 1 more Smart Citation

Health system cost of delivering routine vaccination in low- and lower-middle income countries: what is needed over the next decade?

Lydon

Gandhi

Vandelaer

et al. 2014

Bull. World Health Organ.

Self Cite

View full text Add to dashboard Cite

“…In the 1990's, hepatitis B and Haemophilus influenza type b vaccines were recommended where the disease burden was high [4]. Immunisation has helped to eradicate smallpox [5]. It has lowered the global incidence of polio by 99% [2].…”

Section: Introductionmentioning

confidence: 99%

Complete Child Immunisation: A Cluster Analysis of Positive Deviant Regions in Ghana

Kyere¹

2017

J Vaccines Vaccin

View full text Add to dashboard Cite

“…According to recent estimates, it will require roughly USD $50-60 billion to scale up coverage for routinely recommended and new vaccinations-including those against HPV and prospective vaccinations against dengue and malaria-in 94 low-and middleincome countries from 2011 to 2020 (9). By comparison, the current biennial budget of the World Health Organization is roughly USD $4 billion (10).…”

mentioning

confidence: 99%

Valuing vaccination

Bärnighausen

Bloom

Cafiero-Fonseca

et al. 2014

Proc. Natl. Acad. Sci. U.S.A.

166

149

View full text Add to dashboard Cite

Vaccination has led to remarkable health gains over the last century. However, large coverage gaps remain, which will require significant financial resources and political will to address. In recent years, a compelling line of inquiry has established the economic benefits of health, at both the individual and aggregate levels. Most existing economic evaluations of particular health interventions fail to account for this new research, leading to potentially sizable undervaluation of those interventions. In line with this new research, we set forth a framework for conceptualizing the full benefits of vaccination, including avoided medical care costs, outcome-related productivity gains, behavior-related productivity gains, community health externalities, community economic externalities, and the value of risk reduction and pure health gains. We also review literature highlighting the magnitude of these sources of benefit for different vaccinations. Finally, we outline the steps that need to be taken to implement a broad-approach economic evaluation and discuss the implications of this work for research, policy, and resource allocation for vaccine development and delivery.benefit-cost analysis | immunization

show abstract

Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011–2020

Cited by 43 publications

References 6 publications

Health system cost of delivering routine vaccination in low- and lower-middle income countries: what is needed over the next decade?

Health system cost of delivering routine vaccination in low- and lower-middle income countries: what is needed over the next decade?

Complete Child Immunisation: A Cluster Analysis of Positive Deviant Regions in Ghana

Valuing vaccination

Contact Info

Product

Resources

About